On August 6th, Gelunhui reported that Anhui Sunhere Pharmaceutical Excipients (300452.SZ) has added one new pharmaceutical excipient product recently: K25 Polyvinylpyrrolidone has obtained the registration number of the Center for Drug Evaluation (CDE) of the National Medical Products Administration with registration number F20240000334. As of the date of the announcement, Anhui Sunhere Pharmaceutical Excipients has obtained registration numbers for 45 products from CDE.
As part of the polyvinylpyrrolidone series, K25 Polyvinylpyrrolidone has a smaller molecular weight and lower viscosity than K30 and K90 Polyvinylpyrrolidone. The product is a white to milky white powder and its application in formulations is very wide. For example, in tablets, K25 Polyvinylpyrrolidone solution can be used as a binder in wet granulation; in topical and oral suspensions and solutions, it can also be used as a suspending agent, stabilizer or thickener. Mixing many poorly soluble drugs with polyvinylpyrrolidone can increase their solubility.
The addition of new product varieties has expanded the company's production range, which will have a positive impact on the company's future operations. At the same time, we urge investors to invest prudently and pay attention to preventing investment risks.